Development of CRISPR/Cas Genome Editing as a Treatment for Ataxia Telangiectasia

Project: Research

StatusFinished
Effective start/end date1/11/1730/06/21

Funding

Action for AT: £200,000, Action for AT: £40,000

ID: 28655330